JP Morgan Chase’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

JP Morgan Chase’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-468,803	Closed	-$35.2M	–	4972
2015 Q3	$35.2M	Sell	468,803 -20,032	-4%	-$1.5M	0.01%	951
2015 Q2	$36.8M	Buy	488,835 +324,289	+197%	+$17.4M	0.01%	1039
2015 Q1	$8.25M	Buy	164,546 +38,112	+30%	+$1.6M	﹤0.01%	2029
2014 Q4	$4.38M	Sell	126,434 -4,827	-4%	-$168K	﹤0.01%	2488
2014 Q3	$4.3M	Buy	131,261 +1,193	+0.9%	+$42K	﹤0.01%	2460
2014 Q2	$4.99M	Buy	130,068 +10,631	+9%	+$371K	﹤0.01%	2068
2014 Q1	$4.75M	Buy	119,437 +103,524	+651%	+$4.63M	﹤0.01%	2113
2013 Q4	$594K	Buy	+15,913	New	+$660K	﹤0.01%	3403

JP Morgan Chase's KYTH Position: Q4 2015 in Review

JP Morgan Chase sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 468,803 shares — an estimated $35.2M sold.

JP Morgan Chase first reported a position in KYTH in Q4 2013 and held it in 8 quarters. The position peaked at $36.8M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

JP Morgan Chase reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
JP Morgan Chase sold 468,803 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $35.2M.
JP Morgan Chase first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 8 quarters.
JP Morgan Chase's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $36.8M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on JP Morgan Chase's 13F filing for Q4 2015, filed 12 Feb 2016.